<DOC>
	<DOC>NCT02684058</DOC>
	<brief_summary>The purpose of this study is to investigate the activity of dabrafenib in children and adolescent patients with BRAF V600 mutation positive relapsed or refractory high grade glioma.</brief_summary>
	<brief_title>Phase II Pediatric Study With Dabrafenib in HGG Patients</brief_title>
	<detailed_description />
	<mesh_term>Neoplasms</mesh_term>
	<mesh_term>Glioblastoma</mesh_term>
	<mesh_term>Astrocytoma</mesh_term>
	<mesh_term>Medulloblastoma</mesh_term>
	<mesh_term>Gliosarcoma</mesh_term>
	<mesh_term>Ependymoma</mesh_term>
	<mesh_term>Oligodendroglioma</mesh_term>
	<mesh_term>Rhabdoid Tumor</mesh_term>
	<mesh_term>Pinealoma</mesh_term>
	<mesh_term>Hemangiopericytoma</mesh_term>
	<mesh_term>Carcinoma</mesh_term>
	<mesh_term>Choroid Plexus Neoplasms</mesh_term>
	<mesh_term>Ganglioglioma</mesh_term>
	<mesh_term>Nerve Sheath Neoplasms</mesh_term>
	<mesh_term>Dabrafenib</mesh_term>
	<criteria>Diagnosis of High Grade glioma Relapsed, progressed or failed to respond to frontline therapy. Able to swallow capsules Previous treatment with dabrafenib Cancer treatment within the past 3 weeks Stem cell transplant within the past 3 months History of heart disease Pregnant or lactating females</criteria>
	<gender>All</gender>
	<minimum_age>6 Years</minimum_age>
	<maximum_age>17 Years</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>Glioma</keyword>
	<keyword>Anaplastic astrocytoma</keyword>
	<keyword>Glioblastoma</keyword>
	<keyword>Giant cell glioblastoma</keyword>
	<keyword>Gliosarcoma</keyword>
	<keyword>Anaplastic oligodendroglioma</keyword>
	<keyword>Anaplastic oligoastrocytoma</keyword>
	<keyword>Anaplastic ependymoma</keyword>
	<keyword>Choroid plexus carcinoma</keyword>
	<keyword>Anaplastic ganglioglioma</keyword>
	<keyword>Pineal parenchymal tumor</keyword>
	<keyword>Pineoblastoma</keyword>
	<keyword>Medulloblastoma</keyword>
	<keyword>PNET</keyword>
	<keyword>Rhabdoid tumor</keyword>
	<keyword>Perineurioma</keyword>
	<keyword>MPNST</keyword>
	<keyword>Malignant meningloma</keyword>
	<keyword>Anaplastic hemangiopericytoma</keyword>
	<keyword>Dabrafenib</keyword>
	<keyword>Pediatrics</keyword>
	<keyword>Brain neoplasma</keyword>
</DOC>